Literature DB >> 35651464

COVID-19 Vaccination-Induced Cardiomyopathy Requiring Permanent Left Ventricular Assist Device.

Muhammad Z Khan1, Scott Janus2, Sona Franklin1, Vincent Figueredo3, Abdul Baqi4, Rene Alvarez5.   

Abstract

Myocarditis was identified as a rare but serious adverse event that can occur after mRNA-based coronavirus disease 2019 (COVID-19) vaccination, particularly in young males. During the COVID-19 pandemic, we report a case of a young obese male without multiple comorbidities who presented with abdominal pain and was found to have severe myocarditis/cardiomyopathy, which was likely due to mRNA-based COVID-19 vaccination. The patient had left ventricular assist device (LVAD) implantation during hospitalization. Myocarditis/cardiomyopathy may be a rare complication of the mRNA-based COVID vaccine; however, one should maintain a high index of suspicion that these vaccines may cause irreversible cardiomyopathy if the patient had prior COVID-19 infection.
Copyright © 2022, Khan et al.

Entities:  

Keywords:  covid-19; covid-19 and cardiomyopathy; covid-19 vaccination; lvad; myocarditis

Year:  2022        PMID: 35651464      PMCID: PMC9132740          DOI: 10.7759/cureus.24477

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  5 in total

1.  COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.

Authors:  S A Meo; I A Bukhari; J Akram; A S Meo; D C Klonoff
Journal:  Eur Rev Med Pharmacol Sci       Date:  2021-02       Impact factor: 3.507

2.  Myocarditis after Covid-19 Vaccination in a Large Health Care Organization.

Authors:  Guy Witberg; Noam Barda; Sara Hoss; Ilan Richter; Maya Wiessman; Yaron Aviv; Tzlil Grinberg; Oren Auster; Noa Dagan; Ran D Balicer; Ran Kornowski
Journal:  N Engl J Med       Date:  2021-10-06       Impact factor: 91.245

3.  Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection.

Authors:  Martina Patone; Xue W Mei; Lahiru Handunnetthi; Sharon Dixon; Francesco Zaccardi; Manu Shankar-Hari; Peter Watkinson; Kamlesh Khunti; Anthony Harnden; Carol A C Coupland; Keith M Channon; Nicholas L Mills; Aziz Sheikh; Julia Hippisley-Cox
Journal:  Nat Med       Date:  2021-12-14       Impact factor: 53.440

4.  Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.

Authors:  Julia W Gargano; Megan Wallace; Stephen C Hadler; Gayle Langley; John R Su; Matthew E Oster; Karen R Broder; Julianne Gee; Eric Weintraub; Tom Shimabukuro; Heather M Scobie; Danielle Moulia; Lauri E Markowitz; Melinda Wharton; Veronica V McNally; José R Romero; H Keipp Talbot; Grace M Lee; Matthew F Daley; Sara E Oliver
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-07-09       Impact factor: 17.586

Review 5.  Myocarditis With COVID-19 mRNA Vaccines.

Authors:  Biykem Bozkurt; Ishan Kamat; Peter J Hotez
Journal:  Circulation       Date:  2021-07-20       Impact factor: 29.690

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.